Terms: = Skin cancer AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2
10 results:
1. A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.
Herrera-Rios D; Li G; Khan D; Tsiampali J; Nickel AC; Aretz P; Hewera M; Suwala AK; Jiang T; Steiger HJ; Kamp MA; Muhammad S; Hänggi D; Maciaczyk J; Zhang W; Kahlert UD
Sci Rep; 2020 Oct; 10(1):16218. PubMed ID: 33004830
[TBL] [Abstract] [Full Text] [Related]
2. Ectopic expression of SOX18 in Basal cell carcinoma negatively regulates tumour progression.
Villani R; Sim SL; Roy E; Wainwright B; Francois M; Khosrotehrani K
J Dermatol Sci; 2020 Jun; 98(3):179-185. PubMed ID: 32444239
[TBL] [Abstract] [Full Text] [Related]
3. Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors.
Bonyadi Rad E; Hammerlindl H; Wels C; Popper U; Ravindran Menon D; Breiteneder H; Kitzwoegerer M; Hafner C; Herlyn M; Bergler H; Schaider H
Cancer Res; 2016 Apr; 76(7):1690-7. PubMed ID: 26801977
[TBL] [Abstract] [Full Text] [Related]
4. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
[TBL] [Abstract] [Full Text] [Related]
5. Hypoxia promotes uveal melanoma invasion through enhanced Notch and MAPK activation.
Asnaghi L; Lin MH; Lim KS; Lim KJ; Tripathy A; Wendeborn M; Merbs SL; Handa JT; Sodhi A; Bar EE; Eberhart CG
PLoS One; 2014; 9(8):e105372. PubMed ID: 25166211
[TBL] [Abstract] [Full Text] [Related]
6. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and hey1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract] [Full Text] [Related]
7. A knockdown of Maml1 that results in melanoma cell senescence promotes an innate and adaptive immune response.
Kang S; Xie J; Miao J; Li R; Liao W; Luo R
Cancer Immunol Immunother; 2013 Jan; 62(1):183-90. PubMed ID: 22864395
[TBL] [Abstract] [Full Text] [Related]
8. IRF6 is a mediator of Notch pro-differentiation and tumour suppressive function in keratinocytes.
Restivo G; Nguyen BC; Dziunycz P; Ristorcelli E; Ryan RJ; Özuysal ÖY; Di Piazza M; Radtke F; Dixon MJ; Hofbauer GF; Lefort K; Dotto GP
EMBO J; 2011 Nov; 30(22):4571-85. PubMed ID: 21909072
[TBL] [Abstract] [Full Text] [Related]
9. Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells.
Kang S; Yang C; Luo R
Biochem Biophys Res Commun; 2008 Aug; 372(4):629-33. PubMed ID: 18503747
[TBL] [Abstract] [Full Text] [Related]
10. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
Katoh M; Katoh M
Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
[TBL] [Abstract] [Full Text] [Related]
